By MMJ Group Holdings Ltd on Thursday, 11 June 2020
Category: Investment Company

MMJ Group investees continue to gain traction in cannabis and hemp value chain

The company’s share price bounced back from its 12-month low of 6 cents in March 2020 to 12 cents.

Canadian investment Embark Health recently started revenue generating operations

(ASX MMJ) is creating a diversified portfolio of cannabidiol (CBD) and cannabis investments in cultivation, extraction and consumer products with material investments in Embark Health, Weed Me, (), Sequoya, Volero and Bespoke.

The company has also been actively supporting the operational and financial restructuring plans of its investee Harvest One Cannabis Inc ().

MMJ’s investment portfolio as at May 31 2020

Promisingly, Harvest One share price made a material recovery from a 12-month low of 6 Canadian cents in March 2020 to 12 cents.

Incidentally, MMJ share price has also bounced back from 6 Australian cents in March 2020 to 12 cents.

WeedMD

One of MMJ’s largest investees, WeedMD Inc is a federally licensed producer of cannabis products for both the medical and adult-use markets in Canada.

The following is an extract from WeedMD’s presentation providing an update on the company’s indoor and outdoor cultivation and extraction operations:

Related Posts